glp 1 gas and diarrhea Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus GLP-1 and Gut Health: Addressing

Ask how your health is monitored while on these injections, how to help minimize common side effects, and about warning signs or any symptoms that require immediate medical attention

Retatrutide (pronounced reh-TAT-tru-tide) is a synthetic peptide-based therapy that activates three key hormone receptors involved in metabolism: GLP-1 receptor (Glucagon-Like Peptide-1) GIP receptor (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptor This makes Retatrutide a triple agonist a unique advancement over medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) , which activate only one or two of these receptors

You may notice reduced appetite suppression during the gap, but blood levels will rebuild quickly once you resume

When you lose significant weight on a GLP-1 medication, your levothyroxine requirements change

Beyond helping with weight loss, these drugs offer additional health benefits, broadening their role in medical care